| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 4 |
| 1 | CEMIPLIMAB-RWLC | 2 |
| 2 | PACLITAXEL | 2 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| 4 | AMIKACIN SULFATE | 1 |
| 5 | CARBIDOPA AND LEVODOPA | 1 |
| 6 | CARBOPLATIN | 1 |
| 7 | CISPLATIN | 1 |
| 8 | FILGRASTIM | 1 |
| 9 | GEFITINIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEMIPLIMAB-RWLC | 2 | 0.0010 |
| 1 | AMIKACIN SULFATE | 1 | 0.0006 |
| 2 | IVERMECTIN | 1 | 0.0002 |
| 3 | TIGECYCLINE | 1 | 0.0002 |
| 4 | RAMUCIRUMAB | 1 | 0.0002 |
| 5 | GEFITINIB | 1 | 0.0001 |
| 6 | ITRACONAZOLE | 1 | 0.0001 |
| 7 | PEMBROLIZUMAB | 4 | 0.0000 |
| 8 | IXEKIZUMAB | 1 | 0.0000 |
| 9 | FILGRASTIM | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 |
| 1 | Microtubule Inhibitor [EPC] | 2 |
| 2 | Platinum-based Drug [EPC] | 2 |
| 3 | Antiparasitic [EPC] | 1 |
| 4 | Aromatic Amino Acid [EPC] | 1 |
| 5 | Azole Antifungal [EPC] | 1 |
| 6 | Interleukin-17A Antagonist [EPC] | 1 |
| 7 | Kinase Inhibitor [EPC] | 1 |
| 8 | Leukocyte Growth Factor [EPC] | 1 |
| 9 | Pediculicide [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiparasitic [EPC] | 1 | 0.0002 |
| 1 | Pediculicide [EPC] | 1 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 5 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 6 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Aromatic Amino Acid [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 2 | 0.0000 |